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Abstract: The Mediterranean Diet (MedDiet) is significantly associated with anti-inflammatory effects
and a favorable health outcome. During pregnancy, both inflammatory changes and oxidative balance
are essential for a successful outcome, while an unbalanced inflammatory response can be a key
mediator of obstetrical syndromes. The aim of this study is to investigate the adherence to MedDiet
during pregnancy in the 1st and in the 3rd trimester, and to test whether the adherence was associated
with serum adiponectin levels. The study was carried out on 99 normal weight Caucasian women.
The adherence to MedDiet was measured by a 13-point Mediterranean scale. The whole sample
scored 7.2 ± 1.5, with no difference between first and third trimester (p = 0.7). Critical points were:
fruit < 3 servings/day in 77% of the sample, beans < 3 times/week in 89%, fish < 2 times/week in
69%, and nut weekly intake < 30 g in 75%. The serum adiponectin levels significantly decreased from
the first to the third trimester (−16% ± 4%, p = 0.008), which confirms a low-grade inflammatory
condition associated with advancing gestational age. The women who were in the highest tertile of
the adherence to MedDiet had a lower percentage decrease, as compared with those in the lowest
tertile (10% ± 11% vs. −34% ± 3%, p = 0.01). Even if in pregnancy the adiponectin levels are strongly
influenced by the low-grade inflammation, the adherence to MedDiet may modulate this state.
Keywords: Mediterranean Diet; pregnancy; low-grade inflammation; adiponectin
1. Introduction
The Mediterranean Diet (MedDiet), which represents the common dietary pattern among the
populations bordering the Mediterranean Sea, has been widely reported to be a model of healthy eating,
as it contributes to a favorable health status and a better quality of life [1]. This dietary pattern can be
described as a diet characterized by high consumption of plant-based foods, such as fruit, vegetables,
whole cereals, nuts, and legumes; low consumption of red-processed meats and dairy products;
and moderate consumption of fish and poultry [2], with olive oil as the main source of fat. Polyphenols,
vitamins, and fibers derived from plant-based foods, and omega 3 fatty acids derived from fish and nuts,
are the main bioactive compounds associated with the anti-inflammatory and antioxidant properties
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of MedDiet [3]. Although many studies, both in vitro and in vivo, investigated the role of these
compounds on inflammatory and oxidative status, over the past few years, the research carried out in
this field has been mainly focused on estimating adherence to the whole MedDiet, rather than analyzing
the individual components of the dietary pattern [4]. This is because the analyses of single nutrients
ignore some important interactions between the different components of a diet and, more importantly,
because people do not eat isolated nutrients [1]. Therefore, dietary scores estimating adherence to
MedDiet have been found associated with beneficial effects on human health and, in particular, with a
reduction of mortality from cardiovascular diseases and cancer [5]. Pregnancy is a delicate period in a
woman’s life and is characterized by a low-grade inflammatory condition. The evidence in favor of this
is that normal gestation is accompanied by an increased plasma concentration of acute phase reactants
(i.e., fibrinogen, plasminogen activator inhibitor-1, ceruloplasmin, IL-12) and an increased number of
leukocytes. However, if on the one hand, inflammatory changes and oxidative balance are essential for
successful outcome, on the other hand, an unbalanced and exaggerated inflammatory response can be
a key mediator of obstetrical syndromes (preeclampsia and preterm labor) [6]. Some studies, carried
out in adults, suggest that low-grade inflammation can be mitigated by health-promoting behaviors,
such as the healthy eating patterns of MedDiet [7], but no study, to our knowledge, has investigated
this topic during pregnancy.
Adiponectin, an adipose tissue-secreted cytokine, has been shown to improve insulin sensitivity,
to regulate glucose and lipid metabolism, and to have pronounced antiatherosclerosis effects in the
general population [8–11]. Pregnancy is a unique situation, in which there is a physiological but
temporary increase in insulin resistance [12]; the mechanisms responsible for gestational-induced
insulin resistance are not completely understood. Nevertheless, recent studies have reported that, in
addition to estrogen, progesterone, cortisol, and human lactogen [13], adipocytokines—as adiponectin,
which is produced abundantly and exclusively in the adipose tissue—are possible regulators of
insulin resistance and glucose homeostasis in pregnancy. Although there are several studies about
the association between adiponectin and gestational diabetes or preeclampsia [14–18], only a few of
them have focused their attention on the study of normal pregnant subjects, measuring adiponectin
concentration in different trimesters [19,20]. Moreover, some studies have assessed the relationship
between adiponectin and adherence to MedDiet in adults and adolescents, highlighting a direct
association [21,22], but no study has investigated this relationship in pregnancy.
Hence, the primary objective of the present study is to examine adherence to MedDiet during
pregnancy in the first and in the third trimester. A secondary objective is to test whether the adherence
to this dietary pattern is associated with serum adiponectin levels. Finally, we tested whether women
with high adherence to MedDiet have a less substantial decrease in the adiponectin levels.
2. Materials and Methods
2.1. Study Design and Subjects
This study was carried out in a cohort of normal weight Caucasian pregnant women (pre-pregnant
body mass index: 18.5–24.9 kg/m2) recruited at the Department of Woman, Mother and Neonate,
Buzzi Children’s Hospital (Milan, Italy) during the obstetrical and gynecological visits that are planned
in the beginning of pregnancy (within 16th gestational week).
Exclusion criteria were chronic gastrointestinal diseases; pre-pregnant diabetes; celiac disease;
history of eating disorders, such as anorexia or bulimia; vegan, vegetarian, or macrobiotic regimens;
diet-therapy in progress; and non-Caucasian ethnicity.
Anthropometric measures, administration of a modified validated food frequency questionnaire to
assess adherence to MedDiet, and fasting blood sample collection to measure serum adiponectin were
taken 2 days after the visit of recruitment (first trimester) and another time at the visit of the third trimester.
Study procedures were approved by the institutional review board, and each subject provided
written informed consent. The study was carried out according to the Declaration of Helsinki.
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2.2. Anthropometry
Anthropometric measurements were taken by the same operator at the first trimester and third
trimester, according to standard criteria and measuring procedures [23]. Pregnant women were
wearing only underwear. Their weight (to the nearest 0.1 kg) and standing height (SH; to the nearest
0.1 cm) were measured using the same calibrated scale, which had a telescopic vertical steel stadiometer
(SECA 711, Hamburg, Germany).
BMI (body mass index) was calculated as weight (kg)/stature (m2). Pre-pregnancy BMI was
calculated considering self-reported body weight prior to pregnancy.
2.3. Mediterranean Dietary Pattern
Adherence to MedDiet was assessed using a 14-item questionnaire validated in a high-risk
adult population [24]. In accordance with the Guidelines for Pregnancy (Istituto Superiore Sanità,
Ministero della Salute), which recommend abstinence from alcohol, we did not include alcohol
consumption in the index. Thus, we calculated MedScore by taking into account 13 items instead of 14,
which was done in previous studies [25,26]. Only the participants who scored 8 points (MedScore),
instead of 9, were considered as having a good adherence to MedDiet patterns. Adherence to
the Mediterranean Diet is defined according to the following recommendations: olive oil as main
culinary lipid, olive oil ≥ 4 tablespoons/day, vegetables ≥ 2 servings/day, fruit ≥ 3 servings/day,
legumes ≥ 3 servings/week, fish/seafood ≥ 2 servings/week, tree nuts ≥ 30 g/week, poultry more
than red meats, use of sofrito sauce ≥ 2 servings/week, red/processed meat < 1 serving/day,
butter, cream, margarine < 1 serving/day, soda drinks < 1 serving/day, and commercial sweets and
confectionery < 3 servings/week. In accordance with the recommendations, intake was worth 1 point,
while noncompliance with recommendations was worth 0 [24]. The questionnaire was considered
valid only when all the items were duly answered.
2.4. Serum Adiponectin Determination
Participants had their fasting morning blood samples taken on visits during the first trimester
(2 days after recruitment) and the third trimester. Serum was first separated and then centrifuged
and stored at −80 ◦C for later analysis. Blood samples were analyzed for serum adiponectin using
Quantikine-Human Adiponectin/Acrp30 Immunoassay (R&D Systems Inc., Minneapolis, MN, USA).
2.5. Statistical Analysis
Statistical analysis was performed using SPSS version 23 (IBM SPSS Statistics, IBM Corp., Armonk,
NY, USA). All data are expressed as mean ± standard deviation (SD) or error standard (ES) for
continuous variables and as % for categorical variables. Continuous variables between the first
trimester and third trimester were compared using paired Student’s t test, while nominal variables by
were assessed by chi-square test. Linear regression analysis, adjusted for BMI, age, and gestational
age, was used to investigate the association between MedScore (independent) and adiponectin serum
levels, and the association between MedScore and percentage decrease in adiponectin levels from the
first to the third trimester. Women were categorized in tertiles of adherence to MedDiet (expressed as
mean MedScore between the first and the third trimester). Percentage decreases in adiponectin levels
were compared between the extreme of MedScore tertiles using an unpaired t test. Significant values
were considered for p ≤ 0.05.
3. Results
The study was proposed to 127 women, but only 99 completed the study. Seventeen women were
excluded for incomplete food frequency questionnaires, and 11 were excluded because they missed
one of the two study visits.
Table 1 shows the general characteristics of the cohort that we examined in the study (n = 99).
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Table 1. General characteristics of the cohort examined in the study (n = 99).
Mean SD Range
Age (years) 33.5 3.7 25–43
Pre-pregnant BMI (kg/m2) 21.3 1.7 18.6−24.8
Gestational age at 1st trimester (weeks) 14.3 1.6 11–16
Gestational age at 3rd trimester (weeks) 37 1.2 35–38
Weight gain at 3rd trimester (kg) 12.9 0.4 11–14
n %
Nulliparous (n, %) 69 70
Education level (n, %)
Secondary school 4 4.1
High school 30 30.3
Degree 65 65.6
SD: standard deviation.
Table 2 shows the adherence to MedDiet according to the questionnaire results. It can be observed
that the mean Med-Score both at the first (14.3 ± 1.6 weeks) and third trimester (37 ± 1.2 weeks) is less
than 8, which is the minimum value needed to define good adherence to MedDiet.
Table 2. Adherence to the Mediterranean Diet at the first and third trimester (n = 99).
1st Trimester 3rd Trimester p
Mediterranean Score (mean ± SD) 7.2 ± 1.5 7.3 ± 1.4 0.7
Adherence Criterion % %
Use of olive as main culinary lipid 100 100 1
Olive oil ≥ 4 table spoons/day 9 8 0.8
Vegetables ≥ 2 servings/day 82 83 0.9
Fruits ≥ 3 servings/day 22.4 23 0.8
Red/processed meats < 1/day 95 93 0.8
Butter, cream, margarine < 1/day 98 98 1
Soda drinks < 1/day 94 92 0.9
Legumes ≥ 3/week 10 12 0.8
Fish/seafoods ≥ 2/week 30 32 0.8
Commercial sweets and confectionery < 3/week 55 57 0.8
Free nuts (30 g) ≥ 1/week 24 26 0.9
Poultry more than red meats 64 62 0.8
Use of sofrito sauce ≥ 2/week 58 57 0.9
No difference was observed between the first and third trimester. Following are the critical points
of adherence: low consumption of fruits, fish, legumes, and nuts. Good adherence was observed
as far as the use of olive oil as the main lipid is concerned, though the daily intake was lower
than recommended. Based on the questionnaire results, only 7% of the sample regularly consumed
whole cereal.
Table 3 shows serum adiponectin levels. It can be observed that there was a significant decrease
in adiponectin from the first to the third trimester. The percentage decrease in adiponectin levels from
the first to the third trimester was 16% ± 4%.
Table 3. Serum adiponectin levels at the first trimester and third trimester (n = 99).
1st Trimester 3rd Trimester p
Serum adiponectin (µg/mL) (mean ± SE) 11.6 ± 0. 5 8.7 ± 0.4 0.001
SE: standard error. p < 0.05 for significant differences.
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No significant association between adherence to MedDiet and adiponectin levels was found at
either the first trimester nor at the third trimester (first trimester: β = 0.1, p = 0.3; third trimester: β = 0.1,
p = 0.4), however, we found a significant association between the adherence to MedDiet—expressed as
mean MedScore between the first and the third trimester—and the percentage decrease in adiponectin
levels (β = 0.6, p = 0.008). Table 4 shows that if we classify the cohort according to tertiles of adherence
to MedDiet, the women with higher adherence showed less of a decrease in adiponectin levels.
Table 4. Serum adiponectin levels and its variations from the 1st to the 3rd trimester according to
tertiles of adherence to the MedDiet.
Tertile I (n = 51) Tertile II (n = 30) Tertile III (n = 18)
Mean MedScore (1st–3rd trimester) 6.3 ± 0.1 7.7 ± 0.1 9.1 ± 0.2
Adiponectin levels at 1st trimester (µg/mL) 13.1 ± 0.6 11.3 ± 0.9 12.2 ± 0.3
Adiponectin levels at 3rd trimester (µg /mL) 8.6 ± 0.3 8.2 ± 0.6 9.3 ± 1.4
Delta % from the 1st to the 3rd trimester −34% ± 3% −15% ± 7% 10% ± 11%
p-value vs. tertile I 0.14 0.01
Results are expressed as mean ± error standard; p value < 0.05 for significant differences.
4. Discussion
In a cohort of normal weight Caucasian pregnant women, we found that, overall, there was a low
adherence to MedDiet and that this adherence did not change throughout pregnancy. Furthermore,
we found that adiponectin decreased from the 1st to the 3rd trimester and that there was less of
a decrease in adiponectin levels in women with higher adherence to MedDiet. We have decided
to investigate the adherence to MedDiet because, even though the literature supports MedDiet
having anti-inflammatory effects on human health, there are very few studies that investigate
adherence to the diet in pregnancy, where there exists the physiological condition of a low-grade
inflammation. Although the participants in our study were normal weight women, with high
education levels, living in a country in the Mediterranean area, we did not observe good adherence.
In particular, we found poor habits related to consuming the recommended intake of fish, nuts, legumes,
whole cereals, and fruits. These are the MedDiet foods associated with lower inflammation [27] because
of their bioactive compound content, i.e., omega-3, fiber, vitamins, and polyphenols. Although there
are no available data about the adherence to MedDiet in pregnant women in Italy, a recent study
showed that the MedDiet consumption patterns in an Italian population aged 15–64, particularly
those in the young people, are low. As a consequence, it is believed that there is a need to promote
greater awareness of Mediterranean eating habits [28]. The pattern of low consumption of MedDiet
foods was observed in our cohort at the first trimester and remained stable until the third trimester.
This means that food items included in the calculation of MedScore did not change throughout
pregnancy, but we do not know exactly what happened with respect to all dietary habits. Moreover,
we believe that not knowing the women’s adherence to MedDiet and dietary habits before pregnancy
is an important limitation; symptoms linked to pregnancy evolution, such as nausea or food cravings,
could have had an impact on previous eating habits, which we cannot exclude as having affected the
inflammatory status during pregnancy. Many observational studies have examined the association
between MedDiet and inflammatory markers in healthy persons and, in general, those studies report
inverse correlations [29–31]. In a subsample of the Nurse’health Study, a Mediterranean diet index
score was inversely associated with circulating CRP and IL-6, as well as markers of endothelial
dysfunction (the adhesion molecules sICAM-1, sVCAM-1, and soluble E-selectin). Similar findings
were reported in the Attica study, which involved 1514 men and 1528 women: the subjects that had
the greatest adherence to MedDiet (those in the highest tertile) had 17% lower IL-6 and 20% lower
CRP concentrations compared to those in the lowest tertile [31]. Mantzoros et al. [21] reported that
adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin
concentrations in diabetic women. As shown, different biomarkers have been investigated in the
literature to describe inflammatory status associated to MedDiet pattern, but no study has been
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conducted in pregnant women. In our study, we measured serum adiponectin because it is involved in
the development of pregnancy complications, such as insulin resistance, gestational diabetes mellitus,
and preeclampsia. Thus, we investigated whether the adherence to MedDiet could have a link with
serum adiponectin levels during pregnancy.
In agreement with previous studies in normal pregnancies [19], we observed that adiponectin
decreased from the first trimester to the third, which confirms a low-grade inflammatory condition
associated with advancing gestational age; the serum concentrations detected at first and third trimester
are similar to those found in other studies [19,20]. Different from Mantzoros et al. [21], we did not
find any correlation between adiponectin levels and adherence to MedDiet examined at the first and
at third trimester. However, we have to consider that our study was conducted during pregnancy,
which means that the reported habits could be referred to this period only, which we believe is too
short a time to influence inflammatory markers. Moreover, the low-inflammatory state observed in
pregnancy may hide the association between diet and adiponectin levels. It would be useful to plan a
prospective longitudinal study, where the relationship between inflammatory markers and adherence
to MedDiet is investigated before and during pregnancy. Recently, Sureda et al. [22] discovered that
the low adherence to the Mediterranean Diet was directly associated with a worse profile of plasmatic
inflammatory markers. In nonpregnant women aged 18–65 years, they found that this association
was true for hs-CRP and PAI-1, but it was not valid for adiponectin. Even if no association was found
between the adherence to MedDiet and adiponectin levels, it is very interesting to observe that women
with higher adherence to MedDiet showed a lower percentage decrease in adiponectin levels from the
first to the third trimester. This result suggests that, although in pregnancy the adiponectin levels are
probably strongly influenced by the low-grade inflammation, the adherence to MedDiet may modulate
this state. Additional studies are needed to better understand the role of adiponectin in the low-grade
inflammation observed during pregnancy and its association with dietary patterns.
5. Strengths and Limitations
This study provides further information on adherence to MedDiet and inflammatory status
during pregnancy. Nevertheless, this study has several limitations. First, there is a potential lack
of generalizability of the results due to the sample size and to the great predominance of high
education levels in the cohort that we tested. We believe that higher education, coupled with voluntary
participation in the study, had an influence on the women’s motivation to take part in the research.
Secondly, the present cross-sectional design gives limited ability to elucidate the causal relationship
between inflammatory markers and MedDiet patterns: it could be useful to conduct a prospective
study about the adherence to the Mediterranean Diet before pregnancy. Thirdly, although adiponectin
is influenced by the low-grade inflammation state observed in pregnancy, it is an important marker that
it is associated with pregnancy complications and whose decrease in advancing gestational age may
be influenced by the diet, as shown in this study. It could be useful to add other inflammatory markers,
such as CRP, IL-6, and TNF, to have more information about the relationship between MedDiet patterns
and inflammatory response in pregnancy.
6. Conclusions
We found that, overall, there was a low adherence to MedDiet in a cohort of normal weight
Caucasian pregnant women. The lack of association of adiponectin levels at the first and at third
trimester with the adherence to MedDiet suggests that adiponectin levels in pregnancy are likely
strongly affected by the inflammation, however, the smaller decrease in adiponectin from the first
to the third trimester observed in women with higher adherence to MedDiet suggests a role of this
dietary pattern in the modulation of the inflammatory status in advancing gestational age. Our results
and recent evidence about the epigenetic action of diet on fetal programming [32] should encourage
food education before and during pregnancy.
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